Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-related death. Sorafenib, a multitarget angiogenesis inhibitor, is an approved frontline treatment for advanced HCC in Western countries, although a complete response (CR) to treatment is infrequently reported. C...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Commun (Lond)
Main Authors: Brandi, Giovanni, Venturi, Michela, De Lorenzo, Stefania, Garuti, Francesca, Frega, Giorgio, Palloni, Andrea, Garajovà, Ingrid, Abbati, Francesca, Saccoccio, Gioconda, Golfieri, Rita, Pantaleo, Maria Abbondanza, Barbera, Maria Aurelia
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020209/
https://ncbi.nlm.nih.gov/pubmed/29941039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-018-0312-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍